Evolution of Early-Phase Anticancer Drug Investigations in China

This study examines phase 1 anticancer drug clinical trials performed in China from 2017 to 2021.

Detalles Bibliográficos
Autores principales: Wang, Shuhang, Yu, Yue, Jiang, Yale, Zhang, Huishan, Ma, Peiwen, Liu, Gang, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459900/
https://www.ncbi.nlm.nih.gov/pubmed/36074496
http://dx.doi.org/10.1001/jamaoncol.2022.3856
Descripción
Sumario:This study examines phase 1 anticancer drug clinical trials performed in China from 2017 to 2021.

Ejemplares similares